We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Phase I study of the humanized anti-CD40 monoclonal antibody dacetuzumab in refractory or recurrent non-Hodgkin's lymphoma.
- Authors
Advani, Ranjana; Forero-Torres, Andres; Furman, Richard R; Rosenblatt, Joseph D; Younes, Anas; Ren, Hong; Harrop, Kate; Whiting, Nancy; Drachman, Jonathan G
- Abstract
To evaluate the safety, maximum-tolerated dose (MTD), pharmacokinetics, and antitumor activity of dacetuzumab in patients with refractory or recurrent B-cell non-Hodgkin's lymphoma (NHL).
- Publication
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2009, Vol 27, Issue 26, p4371
- ISSN
1527-7755
- Publication type
Journal Article
- DOI
10.1200/JCO.2008.21.3017